JavaScript must be enabled. We apologize for the inconvenience, but please enable JavaScript in your current web browser.

Himuka AM Pharma Corp.

Himuka AM Pharma Corp.

  • Medical Engineering & Biotechnology

Corporate Number|6350001014487

We develop drug seeds with a strong focus on derivatives of a bioactive peptide adrenomedullin (AM) which was discovered at University of Miyazaki (formerly Miyazaki Medical College). Our drug seeds will make significant contributions to resolve unmet medical needs.